Skip to content
Exits and Outcomes
Sign In
Subscribe
Digital health research, news, and analysis from Brian Dolan.
$200/year or
consider an Enterprise subscription
.
Selling to Employers
All Newsletters
93 articles
10 of 10
Livongo clients mostly small commercial pilots? FDA easing.
7.02.19
6
min. Read
Omada’s strategy. Boehringer invests in myopia DTx.
6.27.19
6
min. Read
Omada User Growth. Apple Work Experience. European DTx.
5.16.19
4
min. Read
1 of 10